You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 3, 2024

Investigational Drug Information for Camptothecin

✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Camptothecin?

Camptothecin is an investigational drug.

There have been 154 clinical trials for Camptothecin. The most recent clinical trial was a Phase 3 trial, which was initiated on October 15th 2003.

The most common disease conditions in clinical trials are Neoplasms, Adenocarcinoma, and Lung Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Astex Pharmaceuticals, and Astex Pharmaceuticals, Inc.

Recent Clinical Trials for Camptothecin
64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal CancerPeking Union Medical College HospitalEarly Phase 1
A Trial of NIS793 With FOLFIRINOX in Pancreatic CancerNovartisPhase 2
A Trial of NIS793 With FOLFIRINOX in Pancreatic CancerKimberly PerezPhase 2

See all Camptothecin clinical trials

Clinical Trial Summary for Camptothecin

Top disease conditions for Camptothecin
Top clinical trial sponsors for Camptothecin

See all Camptothecin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.